Bill Begien

Investor Relations Contact at CDT EQUITY INC.

Health Technology

Profile

Bill Begien is Vice President-Investor Relations at NovaBridge Biosciences.
Mr. Begien is Senior Vice President-Investor Relations at CDT Equity, Inc. Mr. Begien was Vice President-Investor Relations at TFF Pharmaceuticals, Inc. from 2022 to 2023.

Bill Begien active positions

Companies	Position	Start
CDT EQUITY INC.	Investor Relations Contact	01/09/2023
NOVABRIDGE BIOSCIENCES	Investor Relations Contact	-

All active positions of Bill Begien

Former positions of Bill Begien

Companies	Position	End
TFF PHARMACEUTICALS, INC.	Investor Relations Contact	01/10/2023

See the detail of Bill Begien's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bill Begien's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures inhaled dry powder drugs for the treatment of pulmonary diseases and conditions	Health Technology
I-Mab I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases	Health Technology
Conduit Pharmaceuticals, Inc. Conduit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty biopharmaceutical company	Health Technology

See company connections